| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 21, 2018 |
Director
Trans History: 19
|
Director | Form 4 | Open market or private purchase of non-derivative or derivative security | 3,894 | $6.47 | 3,894 |
| Aug 21, 2018 |
Chief Operating Officer
Trans History: 22
|
Chief Operating Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Operating Officer
Trans History: 22
|
Chief Operating Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Operating Officer
Trans History: 22
|
Chief Operating Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | 1,413 |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Aug 21, 2018 |
Chief Scientific Officer
Trans History: 21
|
Chief Scientific Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.